SK35198A3 - Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof - Google Patents

Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof Download PDF

Info

Publication number
SK35198A3
SK35198A3 SK351-98A SK35198A SK35198A3 SK 35198 A3 SK35198 A3 SK 35198A3 SK 35198 A SK35198 A SK 35198A SK 35198 A3 SK35198 A3 SK 35198A3
Authority
SK
Slovakia
Prior art keywords
group
substituted
optionally substituted
alkylamino
alkoxy
Prior art date
Application number
SK351-98A
Other languages
English (en)
Slovak (sk)
Inventor
Kazumi Kikuchi
Akira Toyoshima
Toshio Okazaki
Masahiro Takanashi
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of SK35198A3 publication Critical patent/SK35198A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK351-98A 1995-09-20 1996-09-19 Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof SK35198A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24171695 1995-09-20
PCT/JP1996/002696 WO1997011055A1 (fr) 1995-09-20 1996-09-19 Derives d'acryloylguanidine a substitution heteroaryle et leurs composition medicinale

Publications (1)

Publication Number Publication Date
SK35198A3 true SK35198A3 (en) 1999-06-11

Family

ID=17078479

Family Applications (1)

Application Number Title Priority Date Filing Date
SK351-98A SK35198A3 (en) 1995-09-20 1996-09-19 Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof

Country Status (13)

Country Link
EP (1) EP0861831A4 (ko)
KR (1) KR19990063589A (ko)
CN (1) CN1196721A (ko)
AU (1) AU702092B2 (ko)
BR (1) BR9610530A (ko)
CA (1) CA2232497A1 (ko)
CZ (1) CZ84098A3 (ko)
HU (1) HUP9901336A3 (ko)
NO (1) NO981241L (ko)
PL (1) PL326033A1 (ko)
SK (1) SK35198A3 (ko)
WO (1) WO1997011055A1 (ko)
ZA (1) ZA967800B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515854A (ja) * 1995-08-02 2002-05-28 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗薬
US6258829B1 (en) * 1997-03-06 2001-07-10 Toa Eiyo Ltd. Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
JP2003507468A (ja) * 1999-08-23 2003-02-25 スミスクライン・ビーチャム・コーポレイション 脂肪酸シンターゼ阻害剤
EP1695716A2 (en) * 2000-12-26 2006-08-30 Sankyo Company, Limited Medicinal compositions containing diuretics and insulin sensitizers
AU2005264917A1 (en) 2004-06-16 2006-01-26 Wyeth Diphenylimidazopyrimidine and -imidazole amines as inhibitors of B-secretase
CN1968945A (zh) 2004-06-16 2007-05-23 惠氏公司 用于抑制β分泌酶的氨基-5,5-二苯基咪唑酮衍生物
BRPI0606690A2 (pt) 2005-01-14 2009-07-14 Wyeth Corp composto; uso do composto para o tratamento de uma doença ou distúrbio associado com uma atividade excessiva de bace; e composição farmacêutica
BRPI0607094A2 (pt) 2005-02-01 2009-08-04 Wyeth Corp composto da fórmula i; uso do composto para o tratamento de uma doença ou distúrbio associado à atividade excessiva de bace em um paciente que dele necessita; uso do composto para modular a atividade de bace; e composição farmacêutica
KR20070102751A (ko) 2005-02-14 2007-10-19 와이어쓰 β-세크레타제 억제제로서의 아졸릴아실구아니딘
WO2006088694A1 (en) 2005-02-14 2006-08-24 Wyeth SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS
AU2006266167A1 (en) 2005-06-30 2007-01-11 Wyeth Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
TW200738683A (en) 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
CA2623245A1 (en) 2005-09-26 2007-04-05 Wyeth Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
WO2007100536A1 (en) 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
AR065814A1 (es) 2007-03-23 2009-07-01 Wyeth Corp Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados.
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0556674T3 (da) * 1992-02-15 1996-10-14 Hoechst Ag 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation
JP3162572B2 (ja) * 1993-04-28 2001-05-08 住友製薬株式会社 インドロイルグアニジン誘導体
US5401758A (en) * 1993-10-07 1995-03-28 Bristol-Myers Squibb Company Pyridinyl cyanoguanidine compounds
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
JPH0959245A (ja) * 1995-08-25 1997-03-04 Yamanouchi Pharmaceut Co Ltd N−(2−プロペノイル)グアニジン誘導体

Also Published As

Publication number Publication date
EP0861831A1 (en) 1998-09-02
PL326033A1 (en) 1998-08-17
MX9802238A (es) 1998-08-30
WO1997011055A1 (fr) 1997-03-27
AU702092B2 (en) 1999-02-11
EP0861831A4 (en) 1998-11-11
NO981241D0 (no) 1998-03-19
CZ84098A3 (cs) 1998-09-16
AU7000796A (en) 1997-04-09
HUP9901336A2 (hu) 1999-08-30
KR19990063589A (ko) 1999-07-26
CA2232497A1 (en) 1997-03-27
HUP9901336A3 (en) 2000-02-28
BR9610530A (pt) 1999-07-06
ZA967800B (en) 1997-04-03
NO981241L (no) 1998-05-20
CN1196721A (zh) 1998-10-21

Similar Documents

Publication Publication Date Title
SK35198A3 (en) Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof
KR101589332B1 (ko) 2h-크로멘 화합물 및 그의 유도체
US6730792B2 (en) β3 adrenergic agonists
EP1448560B1 (en) 3-SUBSTITUTED OXINDOLE beta 3 AGONISTS
JP5408434B2 (ja) アミド化合物
JP5140854B2 (ja) S1p3受容体拮抗剤
JP4815083B2 (ja) 複素環化合物およびそれの使用方法
EP1448561B1 (en) Beta 3 adrenergic agonists
US20080318958A1 (en) New utilities of tricyclic compounds
WO1999019303A1 (fr) Derives de pyrazole
JP5371775B2 (ja) ヘテロアリール置換カルボキサミド及びnoシンターゼの発現を刺激するためのその使用
KR20080080305A (ko) 트롬보포이에틴 활성 조절 화합물 및 이의 조절 방법
AU2006287513A1 (en) 1, 3-disubstituted indole derivatives for use as PPAR modulators
KR20070100894A (ko) 혈전색전성 장애 치료용 p2y1 수용체 억제제로서의2-페녹시-n-(1,3,4-티아디졸-2-일)피리딘-3-아민 유도체및 관련 화합물
JP2007525482A (ja) イオンチャネルリガンドとしてのアミド化合物およびその使用
PT1258484E (pt) Novos compostos de isoxazol e de tiazol e sua utilização enquanto fármacos
LV12633B (en) REGULATORY AGENT FOR THE RETINOIC PREPARATOR'S FUNCTION
JP2010513341A (ja) ヘテロアリールシクロプロパンカルボキサミド及び薬剤としてのその使用
EP2099753A2 (en) Heteroarylacrylamides and their use as pharmaceuticals
WO2005092304A2 (en) Antifungal agents
KR20150125716A (ko) 새로운 술폰아미드 trpa1 수용체 길항제
JP2011503042A (ja) p38MAPキナーゼ阻害剤
JP2002506033A (ja) ビトロネクチン受容体アンタゴニスト
WO2008053863A1 (fr) Nouveau composé ayant un squelette de 1,4-benzothiazin-3-one ou un squelette de 3,4-dihydroquinolin-2-one
WO2003002540A1 (en) Cyclic diamine compound having five-membered cyclic group